| | SLO | ENG | Cookies and privacy

Bigger font | Smaller font

Show document Help

Title:Prognostic significance of uPA/PAI-1 level, HER2 status, and traditional histologic factors for survival in node-negative breast cancer patients
Authors:ID Fokter Dovnik, Nina (Author)
ID Takač, Iztok (Author)
Files:.pdf Radiology_and_Oncology_2017_Dovnik,_Takac_Prognostic_significance_of_uPAPAI-1_level,_HER2_status,_and_traditional_histologic_factors_for.pdf (577,15 KB)
MD5: 1140BBE72E4FAF57632838893A39663C
 
URL http://www.degruyter.com/view/j/raon.2017.51.issue-1/raon-2016-0024/raon-2016-0024.xml
 
Language:English
Work type:Scientific work
Typology:1.01 - Original Scientific Article
Organization:MF - Faculty of Medicine
Abstract:Background: The association of HER2 status with urokinase plasminogen activator (uPA) and plasminogen activator inhibitor 1 (PAI-1) levels raises the question whether uPA/PAI-1 level carries additional clinically relevant prognostic information independently from HER2 status. The aim of our study was to compare the prognostic value of uPA/PAI-1 level, HER2 status, and traditional prognostic factors for survival in node-negative breast cancer patients. Patients and methods: A retrospective analysis of 858 node-negative breast cancer patients treated in Maribor University Clinical Center, Slovenia, in the years 2000-2009 was performed. Data were obtained from patient medical records. The median follow-up time was 100 months. Univariate and multivariate analyses of disease-free (DFS) and overall survival (OS) were performed using the Cox regression and the Cox proportional hazards model. Results: In univariate analysis, age, tumor size, grade, lymphovascular invasion, HER2 status and UPA/PAI-1 level were associated with DFS, and age, tumor size, grade, and uPA/PAI-1 level were associated with OS. In the multivariate model, the most important determinants of DFS were age, estrogen receptor status and uPA/PAI-1 level, and the most important factors for OS were patient age and tumor grade. The HR for death from any cause in the multivariate model was 1.98 (95% CI 0.83-4.76) for patients with high uPA and/or PAI-1 compared to patients with both values low. Conclusions: uPA/PAI-1 level clearly carries an independent prognostic value regardless of HER2 status in node-negative breast cancer and could be used in addition to HER2 and other markers to guide clinical decisions in this setting.
Keywords:node-negative breast cancer, adjuvant systemic treatment, survival, uPA/PAI-1, HER2 status
Publication status:Published
Publication version:Version of Record
Year of publishing:2017
Number of pages:str. 65-73
Numbering:Letn. 51, št. 1
PID:20.500.12556/DKUM-65612 New window
ISSN:1581-3207
UDC:618.19-006
ISSN on article:1581-3207
COBISS.SI-ID:5717567 New window
DOI:10.1515/raon-2016-0024 New window
NUK URN:URN:SI:UM:DK:3AHMOAMK
Publication date in DKUM:10.05.2017
Views:1477
Downloads:472
Metadata:XML DC-XML DC-RDF
Categories:Misc.
:
Copy citation
  
Average score:(0 votes)
Your score:Voting is allowed only for logged in users.
Share:Bookmark and Share



Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Radiology and oncology
Publisher:Association of Radiology and Oncology
ISSN:1581-3207
COBISS.SI-ID:784507 New window

Licences

License:CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International
Link:http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:10.05.2017

Secondary language

Language:Slovenian
Keywords:dojka, rak (medicina), adjuvantno sistemsko zdravljenje, urokinazni aktivator plazminogena, plazminogen aktivator, inhibitor 1, HER2 status, prognoza


Comments

Leave comment

You must log in to leave a comment.

Comments (0)
0 - 0 / 0
 
There are no comments!

Back
Logos of partners University of Maribor University of Ljubljana University of Primorska University of Nova Gorica